Home › Stocks › AIM

AIM ImmunoTech Inc. (AIM): insider buying, hedge funds & Congress trades

AIM ImmunoTech Inc. (AIM): 16 insider purchases in the last two years.

Insider buying

FiledInsiderSharesPriceValueType
Jun 16, 2025Equels Thomas K
Director, Officer
107$7.70$824no history
Jun 13, 2025Equels Thomas K
Director, Officer
103$8.70$896no history
Apr 23, 2025Kellner Ted D
Director
1,968,504$0.03$59.1Kno history
Apr 23, 2025Equels Thomas K
Director, Officer
1,968,504$0.03$59.1Kno history
Apr 23, 2025Mitchell William M
Director
196,851$0.03$5.9Kno history
Apr 7, 2025Equels Thomas K
Director, Officer
41,000$0.06$2.5Kno history
Apr 4, 2025Rodino Peter W III
Officer
500$0.09$45no history
Mar 6, 2025Equels Thomas K
Director, Officer
50,000$0.13$6.5Kno history
Mar 5, 2025Equels Thomas K
Director, Officer
44,000$0.12$5.3Kno history
Mar 4, 2025Equels Thomas K
Director, Officer
83,334$0.12$10.0Kno history
Jan 21, 2025Equels Thomas K
Director, Officer
20,000$0.21$4.2Kno history
Dec 19, 2024Equels Thomas K
Director, Officer
22,727$0.21$4.8Kno history
Dec 4, 2024Appelrouth Stewart
Director
11,112$0.21$2.3Kno history
Nov 21, 2024Appelrouth Stewart
Director
81,953$0.19$15.6Kno history
Nov 21, 2024Equels Thomas K
Director, Officer
85,000$0.20$17.0Kno history
Nov 20, 2024Equels Thomas K
Director, Officer
60,110$0.18$10.8Kno history

Open-market purchases from SEC Form 4. "Opportunistic" = this insider trades every year but not on a fixed schedule (Cohen, Malloy & Pomorski); "routine" buys carry little information.

Get alerts for AIM

Free account. Know when insiders, famous funds or Congress trade it.

Start free